Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendazac lysine capsules in diabetic nephropathy
CTR20160905Phase 2Active
- Sponsor
- Zhejiang Shapuaisi Pharmaceutical
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendazac in diabetic glomerulosclerosis, sponsored by Zhejiang Shapuaisi Pharmaceutical. Started Jan 2017; status: active.
02
Drugs
bendazac
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on CTR20160905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160905.